Masimo Corporation | Mid-cap | Healthcare
$169.01
0.47%
| Masimo Stock Comparison:
Masimo vs Abbott LaboratoriesMasimo vs Boston ScientificMasimo vs Globus MedicalMasimo vs Bio-RadMasimo vs Bio-Rad LaboratoriesMasimo vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 2.1B
Gross Profit 1.0B 47.96%
Operating Income 37.8M 1.80%
Net Income -304.9M -14.56%
EPS (Diluted) -$5.72

Balance Sheet Metrics

Total Assets 2.6B
Total Liabilities 1.6B
Shareholders Equity 1.1B
Debt to Equity 1.50

Cash Flow Metrics

Operating Cash Flow -249.5M
Free Cash Flow 145.3M

Revenue & Profitability Trend

Masimo Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 2.1B 2.0B 2.0B 1.2B 1.1B
Cost of Goods Sold 1.1B 1.0B 977.0M 430.8M 400.7M
Gross Profit 1.0B 1.0B 1.1B 808.4M 743.0M
Research & Development 222.8M 175.2M 191.4M 137.2M 118.7M
Selling, General & Administrative 743.8M 664.0M 657.4M 395.4M 369.0M
Other Operating Expenses 0 0 0 0 0
Total Operating Expenses 966.6M 839.2M 848.8M 532.6M 487.7M
Operating Income 37.8M 164.3M 210.0M 275.8M 255.3M
Pre-tax Income -305.3M 88.1M 193.4M 274.4M 263.7M
Income Tax -400.0K 6.6M 49.9M 44.8M 23.4M
Net Income -304.9M 81.5M 143.5M 229.6M 240.3M
EPS (Diluted) -$5.72 $1.51 $2.60 $3.98 $4.14

Income Statement Trend

Masimo Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 1.2B 1.2B 1.3B 1.2B 1.1B
Non-Current Assets 1.4B 1.8B 1.9B 648.1M 611.4M
Total Assets 2.6B 3.0B 3.2B 1.9B 1.7B
Liabilities
Current Liabilities 617.7M 563.8M 630.0M 267.7M 233.8M
Non-Current Liabilities 956.1M 1.1B 1.2B 69.1M 71.1M
Total Liabilities 1.6B 1.7B 1.9B 336.8M 304.9M
Equity
Total Shareholders Equity 1.1B 1.4B 1.3B 1.6B 1.4B

Balance Sheet Composition

Masimo Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income -304.9M 81.5M 143.5M 229.6M 240.3M
Operating Cash Flow -249.5M 146.9M 49.2M 249.1M 186.9M
Investing Activities
Capital Expenditures -20.0M -44.0M -52.8M -25.5M -72.5M
Investing Cash Flow -20.1M -37.5M -1.1B -28.1M -75.4M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow -363.4M -297.3M 385.0M -122.4M -54.3M
Free Cash Flow 145.3M 6.4M -26.9M 229.7M 131.2M

Cash Flow Trend

Masimo Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 129.16
Forward P/E 36.23
Price to Book 9.63
Price to Sales 4.29
PEG Ratio 36.23

Profitability Ratios

Profit Margin -23.25%
Operating Margin 21.69%
Return on Equity -25.07%
Return on Assets 1.32%

Financial Health

Current Ratio 2.17
Debt to Equity 72.01
Beta 1.19

Per Share Data

EPS (TTM) -$5.47
Book Value per Share $17.46
Revenue per Share $39.72

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
masi 9.1B 129.16 9.63 -25.07% -23.25% 72.01
Abbott Laboratories 231.9B 17.31 4.75 30.65% 31.89% 27.09
Boston Scientific 149.9B 73.94 6.75 9.50% 11.58% 52.16
Globus Medical 7.8B 43.14 1.91 4.63% 7.39% 2.27
Bio-Rad 6.8B -3.83 1.03 -27.52% -85.16% 20.50
Bio-Rad Laboratories 6.4B -3.60 0.97 -27.52% -85.16% 20.50

Financial data is updated regularly. All figures are in the company's reporting currency.